[go: up one dir, main page]

CO2018008288A2 - Ortomixo type tilapia virus - Google Patents

Ortomixo type tilapia virus

Info

Publication number
CO2018008288A2
CO2018008288A2 CONC2018/0008288A CO2018008288A CO2018008288A2 CO 2018008288 A2 CO2018008288 A2 CO 2018008288A2 CO 2018008288 A CO2018008288 A CO 2018008288A CO 2018008288 A2 CO2018008288 A2 CO 2018008288A2
Authority
CO
Colombia
Prior art keywords
virus
ortomixo
type tilapia
tilapia virus
type
Prior art date
Application number
CONC2018/0008288A
Other languages
Spanish (es)
Inventor
Arnon Dishon
Shlomit Tal
Original Assignee
Kovax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kovax Ltd filed Critical Kovax Ltd
Publication of CO2018008288A2 publication Critical patent/CO2018008288A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

El presente documento describe el aislamiento y caracterización de un virus de ARN de pez recientemente descubierto. También se describen métodos para la detección del virus aislado, una vacuna de virus atenuado vivo y una vacuna de virus inactivado.This document describes the isolation and characterization of a recently discovered fish RNA virus. Methods for the detection of the isolated virus, a live attenuated virus vaccine and an inactivated virus vaccine are also described.

CONC2018/0008288A 2016-01-10 2018-08-06 Ortomixo type tilapia virus CO2018008288A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662276873P 2016-01-10 2016-01-10
US201662352570P 2016-06-21 2016-06-21
PCT/IL2017/050027 WO2017118989A1 (en) 2016-01-10 2017-01-10 Orthomyxo-like virus of tilapia

Publications (1)

Publication Number Publication Date
CO2018008288A2 true CO2018008288A2 (en) 2018-08-21

Family

ID=59274499

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2018/0008288A CO2018008288A2 (en) 2016-01-10 2018-08-06 Ortomixo type tilapia virus

Country Status (6)

Country Link
EP (1) EP3400007A4 (en)
CN (1) CN108778324A (en)
BR (1) BR112018014042A2 (en)
CO (1) CO2018008288A2 (en)
MX (1) MX2018008529A (en)
WO (1) WO2017118989A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108624718A (en) * 2018-06-20 2018-10-09 上海海洋大学 Constant temperature detects the RPA kits and its primer special and probe of Tilapia mossambica lake virus in real time
CA3167972A1 (en) 2020-02-17 2021-08-26 Assaf LOWENTHAL Immune-enhanced aquaculture
CN112194710A (en) * 2020-08-19 2021-01-08 佛山科学技术学院 Recombinant protein coded by tilapia lake virus S8 gene, antibody prepared from recombinant protein and application of recombinant protein
NL2028806B1 (en) * 2021-07-22 2022-06-03 Univ Northwest A&F Tilv-2 protein or gene encoding tilv-2 protein in preparation of subunit vaccine against tilapia lake virus
CN113755645B (en) * 2021-09-30 2023-06-09 厦门海关技术中心 Fluorescent quantitative RT-PCR primer pair and probe for detecting rochu virus, kit and detection method
CN113718061B (en) * 2021-09-30 2023-06-09 厦门海关技术中心 Primer set, kit and method for simultaneously detecting double RT-PCR of rochu virus and viral nervous necrosis virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia lake virus vaccines
CN114057841A (en) * 2014-12-15 2022-02-18 纽约市哥伦比亚大学理事会 Novel tilapia mossambica virus and use thereof

Also Published As

Publication number Publication date
BR112018014042A2 (en) 2019-02-12
CN108778324A (en) 2018-11-09
MX2018008529A (en) 2019-06-06
EP3400007A1 (en) 2018-11-14
EP3400007A4 (en) 2019-08-28
WO2017118989A1 (en) 2017-07-13

Similar Documents

Publication Publication Date Title
CO2018008288A2 (en) Ortomixo type tilapia virus
EA201790532A1 (en) METHODS AND COMPOSITIONS FOR REDUCING IMMUNE RESPONSES AGAINST VIRUS VECTOR FOR TRANSFER
PH12017500858A1 (en) Mocrocyclic peptides useful as immunomodulators
EA201890493A1 (en) Htt repressors and their use
MX373792B (en) CORONAVIRUS.
EA030115B9 (en) Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
MA40765B1 (en) Methods and compositions for inducing protective immunity against human immunodeficiency virus infection
MX2017011655A (en) AZA-PIRIDONA COMPOUNDS AND USES OF THESE.
MX2017005524A (en) METHODS AND COMPOSITIONS FOR THE VIRUS OF RECOMBINANT DENGUE FOR THE DEVELOPMENT OF VACCINES AND DIAGNOSIS.
CL2018000513A1 (en) Pestivirus vaccines for congenital tremors
MX2016000235A (en) METHODS AND COMPOSITIONS FOR DENGUE VIRUS VACCINES.
EA202091567A1 (en) CHIMERIC PROTEINS MIT
EP3104883A4 (en) Tilapia lake virus vaccines
CL2016001745A1 (en) -3'-methyl-abscisic acid (s) and esters thereof
MX381255B (en) AVIAN RHEOVIRUS VACCINES.
PE20190225A1 (en) A METHOD TO REDUCE EGG CONTAMINATION
EP3600404A4 (en) Development of an alternative modified live influenza b virus vaccine
CL2016002256A1 (en) An improved process for the preparation of exametazyme
AR103281A1 (en) COMPOSITIONS, APPLIANCES AND METHODS TO DETERMINE THE pH OF AN ANALYTIC SOLUTION
CL2022001509A1 (en) Inactivated fish orthoreovirus vaccine.
侯荣彦 It’s Me
张岚 Live Like You’re Dying
呱呱 HEROS
李维国 Photo News
李姬坤 My Family